Selin Ercan

Selin Ercan

Auto-generated profile, based on publicly available information

Selin Ercan

Krefting Research Centre, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2025 in European Respiratory Review
Verified
Journal Article
Open access
DLDaniil Lisik
Daniil Lisik
SESaliha Selin Özuygur Ermis
Saliha Selin Özuygur Ermis
GMGregorio P. Milani
Gregorio P. Milani
GSGiulia C. I. Spolidoro
Giulia C. I. Spolidoro
SESelin Ercan
Selin Ercan
BNBright I. Nwaru
Bright I. Nwaru
Introduction: Numerous studies have characterised trajectories of asthma and allergy in children using machine learning, but with different techniques and mixed findings. The present work aimed to summarise the evidence and critically appraise the methodology.Methods: 10 databases were searched. Screening, data extraction and quality assessment were performed in pairs. Trajectory characteristics were tabulated and visualised. Associated risk factor and outcome estimates were pooled using a random-effects meta-analysis.Results: 89 studies were included. Early-onset (infancy) persistent, mid-onset (∼2–5 years) persistent, early-onset early-resolving (within ∼2 years) and early-onset mid-resolving (by ∼3–6 years) wheezing and eczema, respectively, were the most commonly identified disease trajectories. Intermediate/transient trajectories were rare. Male sex was associated with a higher risk of most wheezing trajectories and possibly with early-resolving eczema, while being slightly protective against mid-onset persistent eczema. Parental disease/genetic markers were associated with persistent trajectories of wheezing and eczema, respectively. Prenatal (and less so postnatal) tobacco smoke exposure was associated with most wheezing trajectories, as were lower respiratory tract infections in infancy (particularly with the early-onset resolving patterns). Most studies (69%) were of low methodological quality (particularly in modelling approaches and reporting). Few studies investigated allergic multimorbidity, allergic rhinitis and food allergy.Conclusions: Childhood asthma/wheezing and eczema can be characterised by a few relatively consistent trajectories, with some actionable risk factors such as pre-/postnatal smoke exposure. Improved computational methodology is warranted to better assess generalisability and elucidate the validity of intermediate/transient trajectories. Likewise, allergic multimorbidity and trajectories of allergic rhinitis and food allergy need to be further elucidated.

12 May 2025 in Expert Review of Respiratory Medicine
Verified
Journal Article
Open access
SESaliha Selin Ozuygur Ermis
Saliha Selin Ozuygur Ermis
SESelin Ercan
Selin Ercan
CMCarina Malmhäll
Carina Malmhäll
HAHelen Adesoba
Helen Adesoba
MSMichael Salisu
Michael Salisu
BNBright I. Nwaru
Bright I. Nwaru
The incidence, prevalence, and disease prognosis of asthma differ between males and females throughout the life course. However, the underlying mechanisms are not known. Sex hormones might have a potential role in asthma pathogenesis. But most studies on the role of sex hormones in asthma have focused on females, with a paucity of evidence in males. This paper provides a comprehensive review of the state-of-the-art on sex steroids in asthma, focusing on males, covering mechanistic, clinical, and epidemiological studies. Literature search was conducted in PubMed in September 2024. Androgen signaling has a protective role in asthma by reducing airway smooth muscle (ASM) contractility and decreasing airway inflammation. In contrast, estrogens promote type 2 (T2) airway inflammation, but the effect on ASM remain controversial. To date, suggested mechanisms have not fully clarify the underlying pathways through which sex steroids modulate ASM and T2 inflammation in asthma. The balance between androgen and estrogen signaling might also play a role. While epidemiological studies support a protective role for androgens, the evidence on onset of puberty and asthma is inconclusive. Larger longitudinal population samples and stratification based on age and obesity are needed to resolve these questions.

31 May 2022 in Journal of Basic and Clinical Health Sciences
Verified
Journal Article
Closed access
AAAylin Ozgen Alpaydin
Aylin Ozgen Alpaydin
BABegum Gorgulu Akin
Begum Gorgulu Akin
SESelin Ercan
Selin Ercan
SÖSevgi Özalevli
Sevgi Özalevli
Background: Specific breathing exercises are reported to improve quality of life and reduce symptoms; although no significant benefit on lung function or reduction of exacerbation risk. Additionally, inspiratory muscle training (IMT) aims to increase diaphragm and inspiratory muscle endurance. In this regard, IMT has been studied in uncontrolled asthma patients to investigate its effect on respiratory symptoms and pulmonary functions. Methods: Twenty-one uncontrolled and partially controlled asthmatic patients were included in the study. Asthma control test (ACT), asthma quality of life questionnaire (AQLQ), and spirometric evaluations were performed. The study population was randomized into two groups. The standard care group (n=10) received standard medical treatment while the intervention (n=11) group practiced a portable threshold IMT device following standard medical treatment. Results: The study was completed by 15 patients due to 6 lost follow up (one intervention group and 5 standard care) and one asthma exacerbation. We have found that the intervention group tended to have increased pulmonary function test parameters and AQLQ scores, moreover; MIP values and ACT scores have statistically significant increases after IMT(p=0.01, p=0.02 respectively). Conclusion: Add-on IMT to standard medical treatment could improve asthma control by strengthening inspiratory muscles in uncontrolled asthmatic patients. IMT could be considered in the non-pharmacological treatments of uncontrolled asthmatic patients. Despite the limited number of patients, this study revealed that IMT might have positive outcomes for uncontrolled asthma patients.

18 September 2025 in Clinical and Translational Allergy
Verified
Journal Article
Open access
RAReshed Abohalaka
Reshed Abohalaka
SESelin Ercan
Selin Ercan
LLLauri Lehtimäki
Lauri Lehtimäki
SESaliha Selin Özuygur Ermis
Saliha Selin Özuygur Ermis
DLDaniil Lisik
Daniil Lisik
HKHannu Kankaanranta
Hannu Kankaanranta
Background: Fractional exhaled nitric oxide (FENO) is used to differentiate asthma inflammatory phenotypes and guide its management. However, data on FENO reference values in a representative adult population is limited. We aim to derive reference values and determinants of FENO in a representative adult population.Methods: The West Sweden Asthma Study is a clinical‐epidemiological population‐representative study of randomly selected adults in Western Sweden. From this cohort, 943 subjects participated in comprehensive clinical investigations, including skin prick testing (SPT), specific immunoglobulin E (sIgE) analysis, and FENO measurement. Clinical allergy was defined as co‐occurrence of atopy (positivity to SPT or sIgE) and self‐reported allergic symptoms to the same allergen family. FENO levels were analysed in relation to the presence or absence of clinical allergy, asthma, and other factors.Results: The 95th percentile of FENO ranged from 34 parts per billion (ppb) in those between 30 and 40 years old to 52 ppb in those ≤ 30 years old in the entire sample (N = 943), and from 26 to 37 ppb in those without clinical allergy, asthma, or chronic obstructive pulmonary disease (COPD) (n = 587), depending on age. Sex, smoking, clinical allergy, atopy, asthma, and hypertension influenced FENO levels, meanwhile, age, asthma, clinical allergy, and reversibility‐related variables were significant determinants of FENO levels.Conclusion: The 95th percentile (upper normal limit) for FENO ranges from 34 to 52 ppb overall, and from 26 to 37 ppb in those without clinical allergy, asthma, or COPD, depending on age. These findings provide a guide for interpreting FENO in the general population.

1 May 2022 in Turkish Thoracic Journal
Verified
Journal Article
Open access
SESelin Ercan
Selin Ercan
BEBegum Ergan
Begum Ergan
SOSaliha Selin Ozuygur
Saliha Selin Ozuygur
PKPervin Korkmaz
Pervin Korkmaz
MTMehmet Sezai Tasbakan
Mehmet Sezai Tasbakan
OKOguz Kilinc
Oguz Kilinc
Tocilizumab,COVID-19,mortality,biomarkers,CALL score

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
SESelin Ercan
Selin Ercan
AAAylin Ozgen Alpaydin
Aylin Ozgen Alpaydin
ACAli Canturk
Ali Canturk
EAEmre Ruhat Avci
Emre Ruhat Avci
SESaliha Selin Ozuygur Ermis
Saliha Selin Ozuygur Ermis
NGNaciye Sinem Gezer
Naciye Sinem Gezer
Background: Although fixed airway obstruction on spirometry is crucial for COPD diagnosis, it might be insufficient to identify subjects with pre-COPD. Quantitative computerized tomography (CT) measurements might be helpful to distinguish the subjects with pre-COPD. Thus, we aimed to compare quantitative CT findings of subjects with pre-COPD and COPD. Methods: Subjects who were admitted to our clinic with chronic respiratory symptoms and were evaluated for COPD as a pre-diagnosis were included in the study. Subjects were categorized as COPD and pre-COPD groups according to the FEV1/FVC ratio. Thorax CT voxel-based attenuation analysis was performed by Myrian® Expert software(Intrasense SA-1231, Montpellier, France). Attenuation values lower than -950 Hounsfield Units (HU) were defined as emphysema. Results: Of 163, 106 COPD and 57 pre-COPD cases were included. COPD group had significantly higher lung volume (5683 ml vs 4921 ml, p=0.001) and lower mean attenuation value (-830.0 HU vs -808.2 HU, p<0.001) than the pre-COPD group. Moreover, the COPD group had a higher emphysema percentage than the pre-COPD group (3.87% vs 0.28%, p<0.001). Conclusion: Quantitative CT of pre-COPD demonstrated radiologic findings that might help to corroborate COPD diagnosis, which was also associated with the severity of the airflow obstruction and be an alternative method for COPD diagnosis when it is difficult to reach spirometry.